Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 3796 AL 3810

Parkinson's Disease: From Bench to Bedside-Advancements in Diagnosis and Therapeutics using Pharmacogenomic Approach

Suhas M, Kadiri SK.

Curr Gene Ther. 2026;26(1):27-52. doi: 10.2174/0115665232342211250207064205.

Balance and Postural Outcomes of Vibration Therapies in Parkinson's Disease: Protocol for a Systematic Review and Meta-Analysis

Seok JW, Kim JD, Kim JU, Park SR.

Inquiry. 2026 Jan-Dec;63:469580261433160. doi: 10.1177/00469580261433160. Epub 2026 Mar 24.

Advancing rehabilitation in Parkinson's disease through virtual reality: a narrative review

Diotaiuti P, Di Siena F, Palombo M, Marotta G, Cavicchiolo E, Di Tore PA, Mancone S.

Front Neurol. 2026 May 14;17:1761459. doi: 10.3389/fneur.2026.1761459. eCollection 2026.

Miro1 in Parkinson's Disease: A Key Regulator of Mitochondrial Homeostasis and Neurodegeneration

Singh G, Kaur S, Aran KR.

Neuromolecular Med. 2026 Mar 7;28(1):15. doi: 10.1007/s12017-026-08917-w.

Distinctive characteristics of dopamine neuron release mechanisms: Insights into Parkinson's Disease

Martino ED, Maduro S, Luchicchi A, Wilhelmus MMM, Orefice NS.

Biomed Pharmacother. 2026 May 28;200:119534. doi: 10.1016/j.biopha.2026.119534. Online ahead of print.

Targeting TREM2 to disentangle neuroinflammation and α-Syn pathological propagation in Parkinson's disease

Chen Y, Wang H, Wang J, Wei J.

Cell Signal. 2026 Jul;143:112485. doi: 10.1016/j.cellsig.2026.112485. Epub 2026 Mar 13.

GLP-1 and Parkinson's Disease: A Comprehensive Review of Biology, Mechanisms and Efficacy

Mezabrovschi R, Gegg ME, Schapira AHV.

Cells. 2026 Apr 29;15(9):804. doi: 10.3390/cells15090804.

Seed Amplification Assays for Parkinson's Disease: A Review of α-Synuclein Assays in Body Fluids and Tissues

Kong W, Satoh K, Shimamura MI, Maeda T, Takahashi K, Kurihara M, Iwata A.

J Neurochem. 2026 May;170(5):e70435. doi: 10.1111/jnc.70435.

Do animal models represent the diversity of clinical Parkinson's disease?

Massaro Cenere M, Schirinzi T, Ledonne A, Mercuri NB.

Curr Opin Neurobiol. 2026 May 26;99:103220. doi: 10.1016/j.conb.2026.103220. Online ahead of print.

Secreted GPNMB enhances uptake of fibrillar alpha-synuclein in a non-cell-autonomous process that can be blocked by anti-GPNMB antibodies

Carceles-Cordon M, Brody EM, Boucher ML, Gallagher MD, Skrinak RT, Unger TL, Penner CK, Berndt AJ, Das S, Lam K, Jaenisch R, Van Deerlin V, Lee EB, Brunden K, Luk K, Chen-Plotkin AS.

medRxiv [Preprint]. 2026 Jan 28:2026.01.26.26344888. doi: 10.64898/2026.01.26.26344888.

Fatigue in Parkinson's disease and management with NIBS

Du X, Ji Q, Tong Y, Wang X, Ding Y, Geng X.

Neurol Sci. 2026 Apr 20;47(5):440. doi: 10.1007/s10072-026-09038-9.

Fed-ComBat: A Generalized Federated Framework for Batch Effect Harmonization in Collaborative Studies

Silva S, Reguig G, Oxtoby NP, Altmann A, Lorenzi M.

ArXiv [Preprint]. 2026 Jan 19:arXiv:2601.14314v1.

Targeting P2X purinergic receptors with suramin alleviates rotenone-induced Parkinson's-like pathology via modulation of mitophagy and NLRP3-pyroptosis: Comparison with metformin

Attia MS, Shahin NN, Kamel AS, Khattab MA, Shabayek MI, Darwish HA, El-Sawalhi MM.

Life Sci. 2026 Jul 15;397:124420. doi: 10.1016/j.lfs.2026.124420. Epub 2026 May 1.

Familial young-onset Parkinson's disease associated with SNCA gene duplication: a case series of three sisters from Turkey

Işeri P, Demiryurek E.

Neurocase. 2026 Feb;32(1):40-50. doi: 10.1080/13554794.2026.2620678. Epub 2026 Feb 25.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias